Banner Image

Frontcourt Ventures

Represented an investor syndication headed by Frontcourt Ventures in connection with its participation in the Series C Preferred Stock financing of SPR Therapeutics, Inc., a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain.